bluuebunny/crossref_metadata_2025_split huggingface dataset:
Flow cytometric measurement of STAT5 phosphorylation in cytomegalovirus‐stimulated T cells
Authors: Bitar Michael , Boettcher Marcus , Boldt Andreas , Hauck Fabian , Köhl Ulrike , Liebert Uwe G. , Magg Thomas , Schulz Marian S. , Sack Ulrich 
Published: December 2020

AbstractCytomegalovirus (CMV)‐specific T cells expand with CMV reactivation and are probably prerequisite for control and protection. Given the critical role STAT5A phosphorylation (pSTAT5A) in T cell proliferation, this study presents a simple and sensitive flow cytometric‐based pSTAT5A assay to quickly identify CMV‐specific T cell proliferation. We determined pSTAT5A in T cells treated with CMV‐specific peptide mix (pp65 + IE1 peptides) from 20 healthy adult subjects and three immunodeficient patients with CARMIL‐2 mutation. After stimulation, the percentage of pSTAT5A+ T cells in CMV‐seropositive (CMV+) subjects significantly increased from 3.0% ± 1.9% (unstimulated) to 11.4% ± 5.9% (stimulated) for 24 h. After 7 days of stimulation, the percentage of expanded T cells amounted to 26% ± 17.2%. Conversely, the percentage of pSTAT5A+ T cells and T cell proliferation from CMV‐seronegative (CMV−) subjects hardly changed (from 3.0% ± 1.3% to 3.7% ± 1.8% and from 4.3% ± 2.1% to 5.7% ± 1.7%, respectively). We analyzed the correlation between the percentage of pSTAT5A+ T cells versus (1) CMV‐IgG concentrations versus (2) the percentage of expanded T cells and versus (3) the percentage of initial CMV‐specific T cells. In immunodeficient patients with CARMIL‐2 mutation, CMV‐specific pSTAT5A and T cell proliferation were completely deficient. In conclusion, flow cytometric‐based pSTAT5A assay represents an appropriate tool to quickly identify CMV‐specific T cell proliferation and helps to understand dysfunctions in controlling other pathogens. Flow cytometric‐based pSTAT5A assay may be a useful test in clinical practice and merits further validation in large studies.
RHAPSODY, Biomarkers and Novel Clinical Trial design in type 2 diabetes (T2D) and prediabetes
Authors: Adams Rachel , Daly Nicole , Robertson Elizabeth , Giordano Giuseppe N. 
Published: December 2020

AbstractDeveloping a novel therapeutic product for the treatment of type 2 diabetes (T2D) is a long, resource‐intensive process. Novel biomarkers could potentially aid clinical trial design by shortening clinical trials or enabling better prediction of at‐risk populations and/or disease progression. Novel clinical trial designs could lead to reduced costs of development and less burden to patients, due to shorter trial duration, and/or less burdensome assessments.
Predominant subtype of heart failure after acute myocardial infarction is heart failure with non‐reduced ejection fraction
Authors: Kamon Daisuke , Sugawara Yu , Soeda Tsunenari , Okamura Akihiko , Nakada Yasuki , Hashimoto Yukihiro , Ueda Tomoya , Nishida Taku , Onoue Kenji , Okayama Satoshi , Watanabe Makoto , Kawakami Rika , Saito Yoshihiko 
Published: December 2020

AbstractAimsPatients who survive acute myocardial infarction (AMI) are at risk of being rehospitalized owing to the occurrence of acute decompensated heart failure (HF). However, the clinical characteristics of HF after AMI, especially the frequency of each HF subtype, are unclear.Methods and resultsWe retrospectively studied 1055 patients with AMI. We excluded 257 patients, who were admitted >48 h after the onset of AMI, died during hospitalization or after discharge, and whose echocardiogram data at index hospitalization and follow‐up data were missing. The remaining 798 patients (mean age: 66.5 ± 11.7 years) were investigated for a mean follow‐up period of 4.9 years. All patients underwent emergency coronary angiography. The mean maximum creatine kinase levels were 2898 ± 2627 IU/L, and mean left ventricular ejection fraction (LVEF) was 58.9 ± 10.2%. Eighty‐one patients (10.2%) were rehospitalized because of unexpected worsening of HF. Echocardiography data were available for 74 of the 81 patients during the acute phase of the second hospitalization, of which 30, 20, and 24 patients (41%, 27%, and 32%, respectively) were diagnosed as having HF with preserved LVEF (LVEF ≥ 50%), HF with mid‐range LVEF (40% ≤ LVEF < 50%), and HF with reduced LVEF (LVEF < 40%), respectively. The ejection fraction during index hospitalization was 58.3 ± 9.7% in the HF with preserved LVEF group, 53.3 ± 10.2% in the HF with mid‐range LVEF group, and 43.3 ± 10.5% in the HF with reduced LVEF group (P < 0.001).ConclusionsThe predominant subtypes of HF after AMI were HF with mid‐range ejection fraction and preserved ejection fraction, or HF with non‐reduced ejection fraction.
How many types of circulation can a boy have during his life? A case of aortic stenosis with a borderline left ventricle
Authors: Koubský Karel , Tláskal Tomáš , Chaloupecký Václav , Janoušek Jan 
Published: December 2020

AbstractSevere aortic stenosis can be accompanied by various degrees of left ventricular underdevelopment. The assessment whether a borderline‐sized left ventricle can or cannot support the systemic circulation is crucial. The decision‐making still remains challenging. We present a case that illustrates that the development of haemodynamic parameters can be difficult to estimate, even in the long term. The patient went from biventricular to univentricular circulation and back and could finally be palliated by heart transplantation. Modern technology including long‐term mechanical cardiac support as a bridge to candidacy and drug therapy for pulmonary hypertension were vital to successfully combat a previously lethal disease.
Prevalence and prognostic value of the coexistence of anaemia and frailty in older patients with heart failure
Authors: Tanaka Shinya , Kamiya Kentaro , Saito Hiroshi , Saito Kazuya , Ogasahara Yuki , Maekawa Emi , Konishi Masaaki , Kitai Takeshi , Iwata Kentaro , Jujo Kentaro , Wada Hiroshi , Kasai Takatoshi , Hamazaki Nobuaki , Nozaki Kohei , Nagamatsu Hirofumi , Ozawa Tetsuya , Izawa Katsuya , Yamamoto Shuhei , Aizawa Naoki , Wakaume Kazuki , Oka Kazuhiro , Momomura Shin‐ichi , Kagiyama Nobuyuki , Matsue Yuya 
Published: December 2020

AbstractAimsThere have been no investigations of the prevalence and clinical implications of coexistence of anaemia and frailty in older patients hospitalized with heart failure (HF) despite their association with adverse health outcomes. The present study was performed to determine the prevalence and prognostic value of the coexistence of anaemia and frailty in hospitalized older patients with HF.Methods and resultsWe performed post hoc analysis of consecutive hospitalized HF patients ≥65 years old enrolled in the FRAGILE‐HF, which was the prospective, multicentre, observational study. Anaemia was defined as haemoglobin < 13 g/dL in men and <12 g/dL in women, and frailty was evaluated according to the Fried phenotype model. The study endpoint was all‐cause mortality. Of the total of 1332 patients, 1217 (median age, 81 years; 57.4% male) were included in the present study. The rates of anaemia and frailty in the study population were 65.7% and 57.0%, respectively. The patients were classified into the non‐anaemia/non‐frail group (16.6%), anaemia/non‐frail group (26.4%), non‐anaemia/frail group (17.7%), and anaemia/frail group (39.3%). A total of 144 patients died during 1 year of follow‐up. In multivariate analyses, only the anaemia/frail group showed a significant association with elevated mortality rate (adjusted hazard ratio, 1.94; 95% confidence interval, 1.02–3.70; P = 0.043), compared with the non‐anaemia/non‐frail group after adjusting for other covariates.ConclusionsCoexistence of anaemia and frailty are prevalent in hospitalized older patients with HF, and it has a negative impact on mortality.
Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
Authors: Fudim Marat , Ashur Nicolas , Jones Aaron D. , Ambrosy Andrew P. , Bart Bradley A. , Butler Javed , Chen Horng H. , Greene Stephen J. , Reddy Yogesh , Redfield Margaret M. , Sharma Abhinav , Hernandez Adrian F. , Felker Gary Michael , Borlaug Barry A. , Mentz Robert J. 
Published: December 2020

AbstractAimsHeart failure with preserved ejection fraction (HFpEF) is a heterogeneous condition, and tissue congestion manifested by oedema is not present in all patients. We compared clinical characteristics, exercise capacity, and outcomes in patients with HFpEF with and without oedema.Methods and resultsThis study was a post hoc analysis of pooled data of patients with left ventricular ejection fraction of ≥50% enrolled in the DOSE, CARRESS‐HF, RELAX, ATHENA, ROSE, INDIE, and NEAT trials. Patients were dichotomized by the severity of oedema. Cox proportional hazard regression and generalized linear regression models were used to assess associations between oedema, symptoms, and clinical outcomes. The ambulatory cohort included 393 patients (228 with and 165 without oedema), and the hospitalized cohort included 338 patients (249 with ≥moderate oedema and 89 with mild or none). Among ambulatory patients, patients with oedema had a higher body mass index (35.2 kg/m2 [inter‐quartile range, IQR 30.5, 41.6] vs. 31.6 kg/m2 [IQR 27.9, 36.3], P < 0.001), greater burden of co‐morbidities, higher intravascular pressures estimated on physical examination (elevated jugular venous pressure: 50% vs. 24.7%, P < 0.001), poorer renal function (creatinine: 1.2 mg/dL [IQR 0.9, 1.5] vs. 1 mg/dL [IQR 0.8, 1.3], P = 0.003), and lower peak VO2 (adjusted mean difference −1.04 mL/kg/min, 95% confidence interval [−1.71, −0.37], P < 0.003). Among hospitalized patients, despite greater in‐hospital fluid/weight loss in the ≥moderate oedema group, there was no difference in the improvement in dyspnoea by the visual analogue scale or well‐being visual analogue scale from baseline to 3–4 days and no statistically significant difference in the rate of 60 day rehospitalization/death (adjusted hazard ratio 1.44, 95% confidence interval [0.87, 2.39], P = 0.156).ConclusionsPatients with HFpEF and oedema display higher body mass, greater burden of co‐morbidities, and more severe exercise intolerance, but clinical responses to treatment appear similar. Further research is required to better understand the nature of volume distribution in different HFpEF phenotypes.
Recent progress in the LC–MS/MS analysis of oxidative stress biomarkers
Authors: Andries Asmin , Rozenski Jef , Vermeersch Pieter , Mekahli Djalila , Van Schepdael Ann 
Published: December 2020

AbstractThe presence of a dynamic and balanced equilibrium between the production of reactive oxygen (ROS) and nitrogen (RNS) species and the in‐house antioxidant defense mechanisms is characteristic for a healthy body. During oxidative stress (OS), this balance is switched to increased production of ROS and RNS, exceeding the capacity of physiological antioxidant systems. This can cause damage to biological molecules, leading to loss of function and even cell death. Nowadays, there is increasing scientific and clinical interest in OS and the associated parameters to measure the degree of OS in biofluids. An increasing number of reports using LC–MS/MS methods for the analysis of OS biomarkers can be found. Since bioanalysis is usually complicated by matrix effects, various types of cleanup procedures are used to effectively separate the biomarkers from the matrix. This is an essential part of the analysis to prepare a reproducible and homogenous solution suitable for injection onto the column. The present review gives a summary of the chromatographic methods used for the determination of OS biomarkers in both urine and plasma, serum, and whole blood samples. The first part mainly describes the biological background of the different OS biomarkers, while the second part reports examples of chromatographic methods for the analysis of different metabolites connected with OS in biofluids, covering a period from 2015 till early 2020. The selected examples mainly include LC–MS/MS methods for isoprostanes, oxidized proteins, oxidized lipoproteins, and DNA/RNA biomarkers. The last part explains the clinical relevance of this review.
Optimization of fortified sponge cake by nettle leaves and milk thistle seed powder using mixture design approach
Authors: Ataei Nukabadi Fariba , Hojjatoleslamy Mohammad , Abbasi Hajar 
Published: December 2020

AbstractPowdered nettle leaf and milk thistle (MT) seed were added to the cake batter with certain percentages selected by the Design‐Expert v. 10 software (0–25, 25–0, 18.75–6.25, 6.25–18.75, and 12.5–12.5). Addition of nettle and MT seeds to the cake reduced the moisture content, volume, and springiness and increased hardness of the samples. 12.5% nettle‐12.5% MT seed had the least hardness and the highest amount of springiness and cohesiveness. The highest BI, WI, SI, L*, a*, and b* and the lowest ΔE were observed in 12.5% nettle‐12.5% MT seed and 25% MT seed samples, respectively. Antioxidant activity and antimicrobial properties were increased in all samples compared to the control sample, so that 6.25% nettle‐18.75% MT exhibited the highest antioxidant activity and antimicrobial properties. The highest levels of quercetin and silymarin were observed in 25% nettle and 25% MT seeds, respectively. In the sensory evaluation, 12.5% nettle‐12.5% MT seed took the best scores regarding flavor, texture, color, and overall acceptance. Based on the lowest hardness, 13.65% nettle‐11.34% MT seed was determined as optimized points by the software, which was equivalent to desirability of 0.72. The optimum sample contained 62.90 mg quercetin and 886.70 mg silymarin. According to the HPLC analysis results, consumption of 10 optimal cakes daily could theoretically decrease the blood sugar level, which requires further studies. The remaining amount of quercetin and silymarin in 2.5 g of nettle leaves and 2.5 g of MT seeds after heating was 11 and 19 mg, respectively. In other words, heat did not have much effect on the destruction of quercetin and silymarin.
Structural abnormalities of cingulate cortex in patients with first‐episode drug‐naïve schizophrenia comorbid with depressive symptoms
Authors: Wei Gao‐Xia , Ge Likun , Chen Li‐Zhen , Cao Bo , Zhang Xiangyang 
Published: December 2020

AbstractDepressive symptoms are common in patients with first‐episode psychosis. However, the neural mechanisms underlying the comorbid depression in schizophrenia are still unknown. The main purpose of this study was to characterize the structural abnormalities of first‐episodes drug‐naïve (FEDN) schizophrenia comorbid with depression by utilizing both volume‐based and surface‐based morphometric measurements. Forty‐two patients with FEDN schizophrenia and 29 healthy controls were recruited. The 24‐item Hamilton Depression Rating Scale (HAMD‐24) was administrated to divide all patients into depressive patients (DP) and non‐depressive patients (NDP). Compared with NDP, DP had a significantly larger volume and surface area in the left isthmus cingulate cortex and also had a greater volume in the left posterior cingulate cortex. Correlation analysis showed that HAMD total score was positively correlated with the surface area of the left isthmus cingulate and gray matter volume of the left isthmus cingulate cortex. In addition, gray matter volume of the left isthmus cingulate was also correlated with the PANSS general psychopathology or total score. The findings suggest that prominent structural abnormalities of gray matter are mainly concentrated on the cingulate cortex in FEDN schizophrenia patients comorbid with depression, which may contribute to depressive symptoms and psychopathological symptoms.
Management of PFAS with the aid of chemical product registries—an indispensable tool for future control of hazardous substances
Authors: Steindal Eirik Hovland , Grung Merete 
Published: December 2020

Abstract
The Nordic countries are in the forefront of international chemical regulation and management by actively developing the domestic policy framework, while simultaneously pushing for more stringent control internationally. Norway, Sweden, and Denmark have been particularly progressive in the regulation of the per- and polyfluoroalkyl substances (PFAS). Restriction proposals have been developed under the EU Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and PFAS have been nominated for global restriction under the Stockholm Convention. A key tool in their work has been the product registries (PRs), where all chemicals imported and produced over a certain reporting limit must be registered by the importers and/or producers. In recent years these PRs have been facing opposition, predominantly from the industry. Simultaneously, and in some contrast, several EU countries are mobilizing for measures to control PFAS as a group. We explored the role of PRs in national and international chemical management. By analyzing the Norwegian PFAS data (2009–2017) reported by industry to the government we observed changes in use and temporal trends. A diversification in use and substitutions to alternative PFAS emerged when new policies were developed, representing a challenge for future control and reduction efforts. Instead of loosening up on reporting obligations, as advocated by some industry representatives, our analysis of the PFAS group argues that governments would benefit from a tighter reporting scheme of problematic compound groups. A comprehensive overview of use, production, and import would contribute to more effective control, thereby saving society and the environment from serious damage and tremendous costs. The Nordic PRs will continue to be important supplements to REACH registration and an indispensable tool for future both national and international regulation on PFAS and other hazardous substances. Integr Environ Assess Manag 2021;17:835–851. © 2020 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC)
KEY POINTS
The Norwegian Product Register (PR) contains detailed yearly information about chemicals used. The PR has been facing opposition, predominantly from the industry. Data from the PR during 2009–2017 for PFAS document changes both in use and temporal trends. The PR is a useful tool in the ongoing work in EU to regulate PFAS as a group.
Synthesis of new azo‐dispersive dyes with benzo[d]imidazole moiety and new bis benzo[d]imidazoles using DABCO‐diacetate as a green media
Authors: Zare Fekri Leila , Nateghi‐Sabet Maryam 
Published: December 2020

AbstractDABCO‐diacetate (1,4‐diazabicyclo[2.2.2]octaniumdiacetate) was synthesized and applied as a green media for the synthesis of new derivatives of benzo[d]imidazole with azo‐linked core and bis benzo[d]imidazoles via condensation reaction of aldehydes and 1,2‐diaminobenzene under solvent‐free conditions. This procedure has benefits such as: good productivity with high yield, short reaction times, easy and efficient process, environmental friendliness, and green aspect of chemistry. DABCO‐diacetate is reusable and can be used for eight runs without notable loss of activity. All of synthesized compounds are new and were characterized completely.
Biodegradation of total petroleum hydrocarbons in oily sludge: a comparative study of biostimulation, bioaugmentation, and combination of methods
Authors: Hamidi Yasser , Ataei Seyed Ahmad , Sarrafi Amir 
Published: December 2020

AbstractBACKGROUNDOne of the major parts of global environmental pollution is petroleum‐derived products. The purpose of this study was the biodegradation of total petroleum hydrocarbons (TPH) in oily sludge using biostimulation and bioaugmentation methods. The oily sludge was dredged from the bottoms of kerosene and oil gas storage tanks, and it was characterized according to American Society for Testing and Materials D1796 and the CHNS (equipment for determination Carbon, Hydrogen, Nitrogen and Sulfour) elements analysis. The TPH biodegradation potential of the indigenous bacteria in the oily sludge was investigated via biostimulation applying mineral salt medium(N). Besides it was compared with bioaugmentation with two oil degrader bacterium, namely Arthrobacter citreus (strain E) and Rhodococcus jostii (strain D), being separated from the oil‐contaminated soil. The gravimetric and GC (Gas Chromatography) methods were used for TPH removal assays.RESULTSThe results indicated that the biodegradation efficiency was dependent on treatment time and microbial species. Increasing pH and TPH biodegradation % for samples were observed over time. The highest removal degradations of hydrocarbons (75.1%) was reported using the inoculum mixture of strains D & E (pH = 7.02) at the 5th week.CONCLUSIONThis method could be used for bioremediation purposes at petroleum hydrocarbon‐contaminated sites as a biological technique. © 2020 Society of Chemical Industry
Application of 3D printing in the treatment of appendicular skeleton fractures: Systematic review and meta‐analysis
Authors: González‐Alonso María , Hermida‐Sánchez Miguel , Martínez‐Seijas Pedro , Ruano‐Ravina Alberto 
Published: December 2020

AbstractThe objective of this study is to evaluate, through a systematic review of the scientific literature and meta‐analysis, the applications of three‐dimensional (3D) printing in the surgical treatment of complex fractures of the appendicular skeleton, mainly in terms of effectiveness and safety. A systematic review of the scientific literature was conducted in MEDLINE (PubMed) and the Cochrane Library combining different keywords. A specific methodological assessment scale was developed and applied to included papers. Ten studies were included; all of them were controlled trials, except for one retrospective observational cohort study. We observed statistically significant differences between the group that used 3D printing and the control group in terms of reduction in surgical time, reduction in the volume of blood lost during surgery and reduction in the number of intraoperative fluoroscopies, in favor of the 3D printing group. No statistically significant differences were observed in terms of fracture healing time, postoperative joint function, or postoperative complications. Meta‐analysis revealed more favorable results for 3D‐printing compared with conventional surgery, with the greatest difference observed for the number of intraoperative fluoroscopies. 3D printing might be considered effective and safe in the surgical treatment of anatomically complex appendicular skeleton fractures, in terms of reducing surgical time, lost blood volume, and radiation exposure of surgeons and patients.